#ClickTherapeutics has won the first-ever #FDA approval for a treatment for the negative symptoms of #schizophrenia – a #digitaltherapeutic (DTx) called #Motivista.
@pharmaphorum.bsky.socialExplore
@pharmaphorum.bsky.social
@pharmaphorum.bsky.social#ClickTherapeutics has won the first-ever #FDA approval for a treatment for the negative symptoms of #schizophrenia – a #digitaltherapeutic (DTx) called #Motivista.